Table 7.
Tolerability, side effects, patient experience, and costs of barrier film use.
| authors | side effects with barrier film (%) |
experience (%) |
costsb |
||||
|---|---|---|---|---|---|---|---|
| itching | rash | blisters | preferred | recommend | number of films (n) | price (EUR)c | |
| Herst et al. | 4 | 0 | 0 | 92 | N/A | 10 | 71.48 |
| Schmeel et al. (a) | 16 | 8 | 7 | N/A | 6 | 20.00 | |
| Møller et al. | 9a | 9a | 3 | 76 | 84 | 8 | N/A |
| Schmeel et al. (b) | 8 | 5 | 0 | 77 | 89 | N/A | 20.00 |
| Behroozian et al. | 0 | 1 | 0 | N/A | 21 | 62.73 | |
| total | 7 | 5 | 2 | 82 | 87 | 11 | 51.40 |
N/A = not available.
a
Møller et al. only reported the combined prevalence of itching and rash, which was 9%.
b
Mean per patient to cover the treated breast/chest wall over the entire treatment course. The respective number of films and price for the first 4 trials (where only either the medial or lateral compartment was covered with barrier film) were doubled to estimate the actual number of films and costs for the entire breast/chest wall.
c
Costs for raw material in the form of barrier film. Costs yielded by application of barrier film by a trained healthcare provider are not included.